On May 4, 2022, the environmental protection acceptance meeting for the completion of the technical transformation project of Wanbangde Pharmaceutical Group Co., Ltd. with an annual output of 980 tons of norfloxacin (front-end supplementation) was held in the company's conference room. The acceptance team checked and verified the implementation of the environmental protection work of this project on site. After careful research and discussion, they formed inspection opinions and put forward rectification requirements. All rectification contents have been completed. Construction Project Management Regulations and the relevant requirements for self-acceptance of enterprises, the acceptance opinions of this project are now publicized as follows:

1. Basic information of the project

Wanbangde Pharmaceutical Group Co., Ltd. implemented a technical transformation project of norfloxacin (front-end supplement) with an annual output of 980 tons at No. 18 Beisha Road, Shangma Industrial Zone, Shitang Town, Wenling City (Shangma old factory area). At present, the construction of the production line, related auxiliary equipment and environmental protection facilities with an annual output of 980 tons of norfloxacin has been actually completed. After the project is completed, the annual production capacity of 980 tons of norfloxacin crude will be formed.

2. Self-acceptance and publicity

Public content: acceptance report, acceptance team comments. (See attachments)

Publishing time: May 13, 2022 - June 10, 2022

During the publicity period, if you have any objection to the above publicity content, please give feedback in writing. The individual must sign the real name, and the unit must affix the official seal.

Contact: Chen Xianmu

Tel: 17816559376

Address: No. 18, Beisha Road, Shangma Industrial Zone, Shitang Town, Wenling City